RLMD

Relmada Therapeutics Inc

NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2014-03-03

$4.39

-0.15 (-3.19%)

last quote

Want the full multi-source brief on RLMD?

The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.

open in agent

Today

Open

$4.39

High

$4.58

Low

$4.33

Previous close

$4.54

Fundamentals

Market cap

$508.28M

P/E (TTM)

—

P/S (TTM)

—

P/B

4.09x

Gross margin

—

Operating margin

—

Net margin

—

Rev growth (YoY)

—

EPS growth (YoY)

—

ROE

-71.22%

52W high

$8.00

52W low

$1.13

Beta

0.57x

Industry peers

by market cap

ARVN-3.81%EOLS-0.50%ZVRA+1.50%AVIR+0.96%BIOA-2.06%NIKA+0.00%VREO.CN CL.CN

Upcoming earnings

next 30 days

2026-11-11in 68 days

Q3 2026EPS est $-0.15

Recent SEC filings

CIK 1553643filing-language history →

SCHEDULE 13G/A2026-08-14

79 KB

8-K2026-08-06

12,329 KB

10-Q2026-08-06reports 2026-06-30

4,719 KB

SCHEDULE 13G2026-07-29

11 KB

8-K2026-07-28

232 KB

SCHEDULE 13G2026-06-22

16 KB

SEC EDGAR Yahoo Finance TradingView Company website

This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial